Please login to your online account to display your discounted pricing

anti-p53, Clone: DO7, Novus Biologicals™

Manufacturer: novus biologicals canada  NBP2294191ML

 View more versions of this product


For Research Use Only

Catalog No. NBP2294191M

  • / Each

Description & Specifications


Immunogen A recombinant protein fragment specific to p53 was used as immunogen for the DO7 antibody.
Applications Flow Cytometry
Applications Immunocytochemistry
Applications Immunofluorescence
Applications Immunohistochemistry (Frozen)
Applications Immunohistochemistry (Paraffin)
Applications Immunoprecipitation
Applications Western Blotting
Host Species Mouse
Isotype κ
Regulatory Status RUO
Clone DO7
Cross Reactivity Bovine
Cross Reactivity Human
Cross Reactivity Primate
Antigen p53
Quantity 1mL
Primary or Secondary Primary
Monoclonal or Polyclonal Monoclonal
Formulation Culture Medium
Conjugate Unlabeled
Gene Accession No. P04637
Gene ID (Entrez) 7157
Test Specificity Recognizes a 53kDa protein, which is identified as p53 suppressor gene product. It reacts with the mutant as well as the wild form of p53. Its epitope maps within the N-terminus (aa 37-45) of p53. Monoclonal antibody PAb1801 does not block the binding of DO-7 MAb to p53 in an ELISA test. p53 is a tumor suppressor gene expressed in a wide variety of tissue types and is involved in regulating cell growth, replication, and apoptosis. It binds to MDM2, SV40 T antigen and human papilloma virus E6 protein. Positive nuclear staining with p53 antibody has been reported to be a negative prognostic factor in breast carcinoma, lung carcinoma, colorectal, and urothelial carcinoma. Anti-p53 positivity has also been used to differentiate uterine serous carcinoma from endometrioid carcinoma as well as to detect intratubular germ cell neoplasia. Mutations involving p53 are found in a wide variety of malignant tumors, including breast, ovarian, bladder, colon, lung, and melanoma.
Format Concentrated